Analyst Price Targets — BCPC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 3, 2026 10:56 am | Raghuram Selvaraju | H.C. Wainwright | $215.00 | $167.56 | StreetInsider | Balchem (BCPC) PT Raised to $215 at H.C. Wainwright |
| August 3, 2026 10:07 am | — | UBS | $215.00 | $167.56 | TheFly | Balchem price target raised to $215 from $190 at H.C. Wainwright |
| December 5, 2025 10:13 am | — | Redburn Partners | $162.00 | $153.35 | TheFly | Balchem initiated with a Neutral at Rothschild & Co Redburn |
| August 4, 2025 12:27 pm | — | H.C. Wainwright | $189.00 | $155.39 | TheFly | Balchem price target raised to $189 from $180 at H.C. Wainwright |
| April 28, 2025 10:07 am | Raghuram Selvaraju | H.C. Wainwright | $180.00 | $153.64 | TheFly | Balchem price target lowered to $180 from $190 at H.C. Wainwright |
| November 5, 2024 11:41 am | Raghuram Selvaraju | H.C. Wainwright | $190.00 | $175.31 | StreetInsider | Balchem (BCPC) PT Raised to $190 at H.C. Wainwright |
| May 2, 2022 6:11 am | — | H.C. Wainwright | $152.00 | $123.20 | Benzinga | HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152 |
Latest News for BCPC
Balchem Corporation posted Q2 results, with EPS of $1.49 beating estimates by $0.07, while surpassing the consensus by $15M and was up 11% YoY. All areas of the business posted impressive results, as the minimum revenue growth for a segment was 8.9%, while the peak was 15% in Animal Nutrition & Health. The stock appears to be trading for a ~9% discount to its fair value right now based on my FCF valuation model.
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several…
MONTVALE, N.J., July 31, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal second quarter ended June 30, 2026.
MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 31, 2026, at 11:00 AM Eastern Time (ET) to review second quarter results.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.